Core Scientific director Eric Weiss buys $50,750 in shares

Published 03/07/2025, 03:08 PM
Core Scientific director Eric Weiss buys $50,750 in shares

Eric Weiss, a director at Core Scientific, Inc. (NASDAQ:CORZ), recently purchased 6,000 shares of the company’s common stock. The transaction, valued at approximately $50,750, was executed at a price of $8.4584 per share on March 6, 2025. The purchase comes as the stock has declined nearly 30% in the past week, with technical indicators suggesting oversold conditions. According to InvestingPro data, analysts maintain a strong buy rating with price targets ranging from $17 to $24. Following this purchase, Weiss’s total holdings in Core Scientific have increased to 221,687 shares. This acquisition represents a significant investment in the $2.31 billion market cap company, as Weiss continues to expand his stake in the firm. For deeper insights into Core Scientific’s valuation and 12 additional exclusive ProTips, check out the comprehensive research report available on InvestingPro.

In other recent news, Core Scientific Inc . reported a challenging fourth quarter of 2024, with a 33% year-over-year decline in total revenue, amounting to $94.9 million, and a net loss of $265 million, widening from $195.7 million in the prior year. The company mined significantly fewer Bitcoins, with only 9.74 mined in Q4 2024 compared to 3,042 in the same period the previous year. Despite these setbacks, Core Scientific successfully reduced its debt by $270 million through Chapter 11 restructuring and ended the year with over $830 million in cash.

Additionally, Core Scientific experienced a decrease in its Bitcoin mining productivity and revenue in February, with an average of 7.7 Bitcoins mined per day, down from 8.3 in January. This decline contributed to a revenue drop from $25.5 million in January to $20.6 million in February. In response, Cantor Fitzgerald analyst Brett Knoblauch lowered the company’s price target to $20.00 from $21.00, though the firm retains an Overweight rating on the stock.

In a strategic move, Core Scientific appointed Jim Nygaard as its new Executive Vice President and Chief Financial Officer, effective March 17, 2025. Nygaard brings extensive experience in investment banking and mergers and acquisitions, which the company hopes will drive growth and increase shareholder value. The company is also expanding its operations by converting several data centers to support artificial intelligence workloads. These developments reflect Core Scientific’s ongoing efforts to navigate a challenging market environment and position itself for future growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.